The DOI matches its Crossref record; 387 of the 391 references it cites were found in a registry or an index.
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment
Open accessAbstract
BACKGROUND: Mild cognitive impairment (MCI) due to Alzheimer's disease is the symptomatic predementia phase of Alzheimer's disease dementia, characterised by cognitive and functional impairment not severe enough to fulfil the criteria for dementia. In clinical samples, people with amnestic MCI are at high risk of developing Alzheimer's disease dementia, with annual rates of progression from MCI to Alzheimer's disease estimated at approximately 10% to 15% compared with the base incidence rates of Alzheimer's disease dementia of 1% to 2% per year. OBJECTIVES: To assess the diagnostic accuracy of structural magnetic resonance imaging (MRI) for the early diagnosis of dementia due to Alzheimer's disease in people with MCI versus the clinical follow-up diagnosis of Alzheimer's disease dementia as a reference standard (delayed verification). To investigate sources of heterogeneity in accuracy, such as the use of qualitative visual assessment or quantitative volumetric measurements, including manual or automatic (MRI) techniques, or the length of follow-up, and age of participants. MRI was evaluated as an add-on test in addition to clinical diagnosis of MCI to improve early diagnosis of dementia due to Alzheimer's disease in people with MCI. SEARCH METHODS: On 29 January 2019 we searched Cochrane Dementia and Cognitive Improvement's Specialised Register and the databases, MEDLINE, Embase, BIOSIS Previews, Science Citation Index, PsycINFO, and LILACS. We also searched the reference lists of all eligible studies identified by the electronic searches. SELECTION CRITERIA: We considered cohort studies of any size that included prospectively recruited people of any age with a diagnosis of MCI. We included studies that compared the diagnostic test accuracy of baseline structural MRI versus the clinical follow-up diagnosis of Alzheimer's disease dementia (delayed verification). We did not exclude studies on the basis of length of follow-up. We included studies that used either qualitative visual assessment or quantitative volumetric measurements of MRI to detect atrophy in the whole brain or in specific brain regions, such as the hippocampus, medial temporal lobe, lateral ventricles, entorhinal cortex, medial temporal gyrus, lateral temporal lobe, amygdala, and cortical grey matter. DATA COLLECTION AND ANALYSIS: Four teams of two review authors each independently reviewed titles and abstracts of articles identified by the search strategy. Two teams of two review authors each independently assessed the selected full-text articles for eligibility, extracted data and solved disagreements by consensus. Two review authors independently assessed the quality of studies using the QUADAS-2 tool. We used the hierarchical summary receiver operating characteristic (HSROC) model to fit summary ROC curves and to obtain overall measures of relative accuracy in subgroup analyses. We also used these models to obtain pooled estimates of sensitivity and specificity when sufficient data sets were available. MAIN RESULTS: We included 33 studies, published from 1999 to 2019, with 3935 participants of whom 1341 (34%) progressed to Alzheimer's disease dementia and 2594 (66%) did not. Of the participants who did not progress to Alzheimer's disease dementia, 2561 (99%) remained stable MCI and 33 (1%) progressed to other types of dementia. The median proportion of women was 53% and the mean age of participants ranged from 63 to 87 years (median 73 years). The mean length of clinical follow-up ranged from 1 to 7.6 years (median 2 years). Most studies were of poor methodological quality due to risk of bias for participant selection or the index test, or both. Most of the included studies reported data on the volume of the total hippocampus (pooled mean sensitivity 0.73 (95% confidence interval (CI) 0.64 to 0.80); pooled mean specificity 0.71 (95% CI 0.65 to 0.77); 22 studies, 2209 participants). This evidence was of low certainty due to risk of bias and inconsistency. Seven studies reported data on the atrophy of the medial temporal lobe (mean sensitivity 0.64 (95% CI 0.53 to 0.73); mean specificity 0.65 (95% CI 0.51 to 0.76); 1077 participants) and five studies on the volume of the lateral ventricles (mean sensitivity 0.57 (95% CI 0.49 to 0.65); mean specificity 0.64 (95% CI 0.59 to 0.70); 1077 participants). This evidence was of moderate certainty due to risk of bias. Four studies with 529 participants analysed the volume of the total entorhinal cortex and four studies with 424 participants analysed the volume of the whole brain. We did not estimate pooled sensitivity and specificity for the volume of these two regions because available data were sparse and heterogeneous. We could not statistically evaluate the volumes of the lateral temporal lobe, amygdala, medial temporal gyrus, or cortical grey matter assessed in small individual studies. We found no evidence of a difference between studies in the accuracy of the total hippocampal volume with reg
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a review summarising 33 studies in structural neuroimaging for the early diagnosis of AD in people with MCI (including 3935 participants) concluded that there is lack of systematic approach in data collection, analysis and interpretation [24].”
From The use of neuroimaging techniques in the early and differential diagnosis of dementia (2023) · cites this paper as [24]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
The Global Deterioration Scale for assessment of primary degenerative dementia
Reisberg, ., Ferris, S. H., de Leon, M. J., & Crook, T. H. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 5,122
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
A Bayesian model of shape and appearance for subcortical brain segmentation
Patenaude, B., Smith, S. M., Kennedy, D. N., & Jenkinson, M. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.046 · Cited by 2,287
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140
Sequence-independent segmentation of magnetic resonance images
Fischl, B. R., Salat, D. H., van der Kouwe, A. J. W., Makris, N., Ségonne, F., Quinn, B. T., & Dale, A. M. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.016 · Cited by 2,117
Empirical evidence of design-related bias in studies of diagnostic tests.
Lijmer, J. G. (1999) · JAMA · doi:10.1001/jama.282.11.1061 · Cited by 1,861
Scheltens, P., Leys, D., Barkhof, F., Huglo, D. G., Weinstein, H. C., Vermersch, P., Kuiper, M. A., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,811
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659
A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations
Rutter, C. M., & Gatsonis, C. (2001) · Statistics in Medicine · doi:10.1002/sim.942 · Cited by 1,510
Mild Cognitive Impairment: Ten Years Later
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.266 · Cited by 1,447
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Prevalence and severity of cognitive impairment with and without dementia in an elderly population
Graham, J., Rockwood, K. J., Beattie, B. L., Eastwood, R., Gauthier, S. G., Tuokko, H. A., & McDowell, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01007-6 · Cited by 1,017
Cuingnet, R., Gérardin, E., Tessieras, J., Auzias, G., Lehéricy, S., Habert, M., Marie Chupin, A., Benali, H., & Olivier Colliot, A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.013 · Cited by 995
Hierarchical Feature Representation and Multimodal Fusion with Deep Learning for AD/MCI Diagnosis
Suk, H.-I., Lee, S.-W., & Shen, D. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.06.077 · Cited by 968
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
Jack, C. R., Petersen, R. C., O’Brien, P. C., & Tangalos, E. G. (1992) · Neurology · doi:10.1212/wnl.42.1.183 · Cited by 880
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000110315.26026.ef · Cited by 827
Sources of Variation and Bias in Studies of Diagnostic Accuracy
Whiting, P. F., Rutjes, A. W., Reitsma, J. B., Glas, A. S., Bossuyt, P. M., & Kleijnen, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00010 · Cited by 804
Hippocampal and entorhinal atrophy in mild cognitive impairment
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., Santi, S. D., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R. P., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256697.20968.d7 · Cited by 749
Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects
Moradi, E., Pepe, A., Gaser, C., Huttunen, H. J., & Tohka, J. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.10.002 · Cited by 740
Zhang, D., & Shen, D. G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.069 · Cited by 689
Schuff, N., Woerner, N., Boreta, L., Kornfield, T., Shaw, L. M., Trojanowski, J. Q., Thompson, P. M., Jack, C. R., Weiner, M. W., & Initiative, T. A. D. N. (2008) · Brain · doi:10.1093/brain/awp007 · Cited by 679
Hippocampus and entorhinal cortex in mild cognitive impairment and early AD
Pennanen, C., Kivipelto, M., Tuomainen, S., Hartikainen, P. H., Hänninen, T., Laakso, M. P., Hallikainen, M., Vanhanen, M., Nissinen, A. M., Helkala, E., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00084-8 · Cited by 668
Research criteria for subcortical vascular dementia in clinical trials
Erkinjuntti, T., Inzitari, D., Pantoni, L., Wallin, A., Scheltens, P., Rockwood, K. J., Román, G. C., Chui, H. C., & Desmond, D. W. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_4 · Cited by 636
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30159-x · Cited by 626
Self-citationLopez, O. L., Jagust, W. J., DeKosky, S. T., Becker, J. T., Fitzpatrick, A., Dulberg, C., Breitner, J., Lyketsos, C., Jones, B., Kawas, C., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.10.1385 · Cited by 618
Comparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e8b8 · Cited by 616
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007) · Brain · doi:10.1093/brain/awm112 · Cited by 607
Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
Davatzikos, C. A., Bhatt, P., Shaw, L. M. J., Batmanghelich, K. N., & Trojanowski, J. Q. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.023 · Cited by 596
Medial temporal lobe function and structure in mild cognitive impairment
Dickerson, B. C., Salat, D. H., Bates, J. F., Atiya, M., Killiany, R., Greve, D. N., Dale, A. M., Stern, C. E., Blacker, D., Albert, M., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20163 · Cited by 579
MRI measures of entorhinal cortex vs hippocampus in preclinical AD
Killiany, R., Hyman, B. T., Gómez‐Isla, T., Moss, M. B., Kikinis, R., Jolesz, F. A., Tanzi, R. E., Jones, K., & Albert, M. (2002) · Neurology · doi:10.1212/wnl.58.8.1188 · Cited by 571
BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease
Gaser, C., Franke, K., Klöppel, S., Koutsouleris, N., Sauer, H., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067346 · Cited by 555
Conversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps
Apostolova, L. G., Dutton, R. A., Dinov, I. D., Hayashi, K. M., Toga, A. W., Cummings, J. L., & Thompson, P. M. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.693 · Cited by 553
Chételat, G., Landeau, B., Eustache, F., Mézenge, F., Viader, F., de la Sayette, V., Desgranges, B., & Baron, J.-C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.015 · Cited by 526
Dickerson, B. C., Goncharova, I. I., Sullivan, M., Forchetti, C., Wilson, R. S., Bennett, D. A., Beckett, L. A., & deToledo‐Morrell, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00271-8 · Cited by 495
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
Jack, C. R., Shiung, M. M., Weigand, S. D., O’Brien, P. C., Gunter, J. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180958.22678.91 · Cited by 492
Fan, Y., Batmanghelich, N., Clark, C. M., & Davatzikos, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.031 · Cited by 477
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve
Querbes, O., Aubry, F., Pariente, J., Lotterie, J.-A., Démonet, J., Duret, V., Puel, M., Berry, I., Fort, J., Celsis, P., et al. (2009) · Brain · doi:10.1093/brain/awp105 · Cited by 467
Bobinski, M., de Leon, M. J., Wegiel, J., DeSanti, S., Convit, A., Saint Louis, L. A., Rusinek, H., & Wisniewski✠, H. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00476-5 · Cited by 455
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
De Leon, M. J., George, A. E., Golomb, J., Tarshish, C., Convit, A., Kluger, A., De Santi, S., Mc Rae, T., Ferris, S. H., Reisberg, B., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00213-8 · Cited by 429
Ewers, M., Walsh, C., Trojanowski, J. Q., Shaw, L. M. J., Petersen, R. C., Jack, C. R., Feldman, H., Bokde, A. L. W., Alexander, G. E., Scheltens, P., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.019 · Cited by 421
Chris Hinrichs, A., Singh, V., Xu, G., & Johnson, S. C. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.10.081 · Cited by 416
Devanand, D. P., Liu, X., Tabert, M. H., Pradhaban, G., Cuasay, K., Bell, K. L., de Leon, M. J., Doty, R. L., Stern, Y., & Pelton, G. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.020 · Cited by 413
MRI and CSF biomarkers in normal, MCI, and AD subjects
Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., Knopman, D. S., Petersen, R. C., & Jack, C. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af79fb · Cited by 406
Lin, W.-M., Tong, T., Gao, Q., Guo, D., Du, X., Yang, Y., Guo, G., Xiao, M., Du, M., Qu, X., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00777 · Cited by 406
Kaye, J. A., Swihart, T., Howieson, D., Dame, A., Moore, M. M., Karnos, T., Camicioli, R., Ball, M., Oken, B., & Sexton, G. (1997) · Neurology · doi:10.1212/wnl.48.5.1297 · Cited by 399
Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
van der Flier, W. M., Pijnenburg, Y. A. L., Prins, N. D., Lemstra, A. W., Bouwman, F. H., Teunissen, C. E., van Berckel, B. N. M., Stam, C. J., Barkhof, F., Visser, P. J., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132306 · Cited by 392
Visser, P. J., Verhey, F. R. J., Hofman, P. A. M., Scheltens, P., & Jolles, J. (2002) · PubMed Central · doi:10.1136/jnnp.72.4.491 · Cited by 359
Convit, A., de Asis, J., de Leon, M. J., Tarshish, C. Y., De Santi, S., & Rusinek, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00107-4 · Cited by 359
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
Whitwell, J. L., Shiung, M. M., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000280575.77437.a2 · Cited by 357
Gomar, J. J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.96 · Cited by 353
Leeflang, M., Moons, K. G. M., Reitsma, J. B., & Zwinderman, A. H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.096032 · Cited by 351
Schünemann, H. J., Mustafa, R., Brozek, J., Santesso, N., Alonso-Coello, P., Guyatt, G., Scholten, R., Langendam, M., Leeflang, M. M., Akl, E. A., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.032 · Cited by 350
Amyloid imaging in mild cognitive impairment subtypes
Wolk, D. A., Price, J. C., Saxton, J. A., Snitz, B. E., James, J. A., López, O. L., Aizenstein, H. J., Cohen, A. D., Weissfeld, L. A., Mathis, C. A., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21598 · Cited by 349
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
Korf, E. S. C., Wahlund, L., Visser, P. J., & Scheltens, P. (2004) · Neurology · doi:10.1212/01.wnl.0000133114.92694.93 · Cited by 348
Marie Chupin, A., Gérardin, E., Cuingnet, R., Boutet, C., Lemieux, L., Lehéricy, S., Benali, H., Garnero, L., & Colliot, O. (2009) · Hippocampus · doi:10.1002/hipo.20626 · Cited by 341
Subtype of Mild Cognitive Impairment and Progression to Dementia and Death
Yaffe, K. S., Petersen, R. C., Lindquist, K. J., Kramer, J. H., & Miller, B. L. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000095427 · Cited by 339
The human hippocampus: An atlas of applied anatomy
Duvernoy, H. M. (1988) · Medical Entomology and Zoology · Cited by 330
MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD
deToledo‐Morrell, L., Stoub, T. R., Bulgakova, M., Wilson, R. S., Bennett, D. A., Leurgans, S. E., Wuu, J., & Turner, D. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.007 · Cited by 330
McEvoy, L. K., Fennema-Notestine, C., Roddey, J. C., Hagler, D. J., Holland, D., Karow, D. S., Pung, C. J., Brewer, J. B., & Dale, A. M. (2009) · Radiology · doi:10.1148/radiol.2511080924 · Cited by 330
The cortical signature of prodromal AD
Bakkour, A., Morris, J. C., & Dickerson, B. C. (2008) · Neurology · doi:10.1212/01.wnl.0000340981.97664.2f · Cited by 321
Chu, C., Hsu, A.-L., Chou, K.-H., Bandettini, P., & Lin, C. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.066 · Cited by 319
Visser, P. J., Scheltens, P., Verhey, F. R. J., Schmand, B., Launer, L. J., Jolles, J., & Jonker, C. (1999) · Journal of Neurology · doi:10.1007/s004150050387 · Cited by 319
Longitudinal volumetric MRI change and rate of cognitive decline
Mungas, D., Harvey, D., Reed, B. R., Jagust, W. J., DeCarli, C., Beckett, L., Mack, W. J., Kramer, J. H., Weiner, M. W., Schuff, N., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000172913.88973.0d · Cited by 311
Westman, E., Muehlboeck, J., & Simmons, A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.04.056 · Cited by 310
Multiple cognitive deficits during the transition to Alzheimer's disease
Bäckman, L., Jones, S., Berger, A., Laukka, E. J., & Small, B. J. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01386.x · Cited by 309
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease.
Lehéricy, S., Baulac, M., Jacques Chiras, C., Pierot, L., Martin-Duverneuil, N., Pillon, B., Deweer, B., Dubois, B., & Marsault, C. (1994) · PubMed Central · Cited by 308
Lebedev, A. V., Westman, E., van Westen, G. J. P., Kramberger, M. G., Lundervold, A. J., Aarsland, D., Soininen, H. S., Kłoszewska, I., Mecocci, P., Tsolaki, M., et al. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.08.023 · Cited by 305
Pruessner, J. C. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.12.1342 · Cited by 297
Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease
Wolz, R., Julkunen, V., Koikkalainen, J. R., Niskanen, E. I., Zhang, D. P., Rueckert, D., Soininen, H. S., Lötjönen, J. M. P., & Initiative, T. A. D. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025446 · Cited by 296
Walhovd, K. B., Fjell, A. M., Brewer, J., McEvoy, L. K., Fennema-Notestine, C., Hagler, D. J., Jennings, R. G., Karow, D., Dale, A. M., & Initiative, T. A. D. N. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1809 · Cited by 279
Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort
Risacher, S. L., Shen, L., West, J. D., Kim, S., McDonald, B. C., Beckett, L. A., Harvey, D. J., Jack, C. R., Weiner, M. W., & Saykin, A. J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.029 · Cited by 276
Eskildsen, S. F., Coupé, P., García-Lorenzo, D., Fonov, V., Pruessner, J. C., & Collins, D. L. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.09.058 · Cited by 269
Synphilin-1 is present in Lewy bodies in Parkinson's disease
Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 269
den Heijer, T., Geerlings, M. I., Hoebeek, F. E., Albert Hofman, D., Koudstaal, P. J., & Breteler, M. M. B. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.57 · Cited by 268
Shaffer, J. L., Petrella, J. R., Sheldon, F. C., Choudhury, K. R., Calhoun, V. D., Coleman, R. E., Doraiswamy, P. M., & Initiative, A. D. N. (2012) · Radiology · doi:10.1148/radiol.12120010 · Cited by 266
Brickman, A. M., Zahodne, L. B., Guzman, V. A., Narkhede, A., Meier, I. B., Griffith, E. Y., Provenzano, F. A., Schupf, N., Manly, J. J., Stern, Y., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.019 · Cited by 265
Chong-yaw Wee, A., Yap, P., Shen, D. G., & Initiative, A. D. N. (2012) · Human Brain Mapping · doi:10.1002/hbm.22156 · Cited by 261
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease
Duara, R., Loewenstein, D. A., Potter, E., Appel, J., Greig, M. T., Urs, R., Shen, Q., Raj, A., Small, B., Barker, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000336925.79704.9f · Cited by 256
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
de Leon, M. J., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Praticò, D., Segal, S., Rusinek, H., Li, J., Tsui, W., Louis, L. A. S., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.003 · Cited by 255
DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment
Kantarci, K., Petersen, R. C., Boeve, B. F., Knopman, D. S., Weigand, S. D., O’Brien, P. C., Shiung, M. M., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000153076.46126.e9 · Cited by 251
Leung, K. K., Barnes, J., Ridgway, G. R., Bartlett, J. W., Clarkson, M. J., Macdonald, K. E., Schuff, N. W., Fox, N. C., & Sebastien Ourselin, A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.03.018 · Cited by 250
Young, J., Modat, M., Cardoso, M. J., Mendelson, A., Cash, D., & Ourselin, S. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.05.004 · Cited by 249
Beheshti, I., Demirel, H., & Matsuda, H. (2017) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2017.02.011 · Cited by 246
Morra, J. H., Tu, Z., Apostolova, L. G., Green, A. E., Avedissian, C., Madsen, S. K., Parikshak, N., Toga, A. W., Jack, C. R., Schuff, N. W., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.043 · Cited by 244
Smith, E. E., Egorova, S., Blacker, D., Killiany, R., Muzikansky, A., Dickerson, B. C., Tanzi, R. E., Albert, M., Greenberg, S. M., & Guttmann, C. R. G. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.23 · Cited by 243
Miller, S. L., Fenstermacher, E., Bates, J., Blacker, D., Sperling, R. A., & Dickerson, B. C. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.124149 · Cited by 241
Liu, F., Chong-yaw Wee, A., Chen, H., & Shen, D. G. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.09.015 · Cited by 239
Cui, Y. J., Liu, B., Luo, S., Zhen, X., Fan, M., Liu, T., Zhu, W., Park, M., Jiang, T., Jin, J. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021896 · Cited by 238
Yue, N. C., Arnold, A. M., Longstreth, W. T., Jr., Elster, A. D., Jungreis, C. A., O’Leary, D. H., Poirier, V. C., & Bryan, R. N. (1997) · Radiology · doi:10.1148/radiology.202.1.8988189 · Cited by 237
Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease
Mungas, D., Reed, B., Jagust, W. J., DeCarli, C. S., Mack, W. J., Kramer, J. H., Weiner, M. W., Schuff, N. W., & Chui, H. C. (2002) · Neurology · doi:10.1212/wnl.59.6.867 · Cited by 235
Smailagic, N., Vacante, M., Hyde, C., Martin, S., Ukoumunne, O. C., & Sachpekidis, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010632.pub2 · Cited by 235
Imaging markers for Alzheimer disease
Frisoni, G. B., Bocchetta, M., Chételat, G., Rabinovici, G. D., de Leon, M. J., Kaye, J. A., Reiman, E. M., Scheltens, P., Barkhof, F., Black, S. E., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829d86e8 · Cited by 226
Self-citationEarly detection of Alzheimer's disease using M RI hippocampal texture
Sørensen, L., Igel, C., Hansen, N. L., Osler, M., Lauritzen, M., Rostrup, E., Nielsen, M., & Initiative, A. D. N. (2015) · Human Brain Mapping · doi:10.1002/hbm.23091 · Cited by 225
From Healthy Aging to Early Alzheimer's Disease: In Vivo Detection of Entorhinal Cortex Atrophy
de Toledo‐Morrell, L., Goncharova, I. I., Dickerson, B. C., WILSON, R. S., & Bennett, D. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06730.x · Cited by 223
Mild Cognitive Impairment in the General Population: Occurrence and Progression to Alzheimer Disease
Palmer, K., Bäckman, L., Winblad, B. G., & Fratiglioni, L. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181753a64 · Cited by 219
Ritchie, C. W., Smailagic, N., Noel-Storr, A. H., Ukoumunne, O. C., Ladds, E. C., & Martin, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010803.pub2 · Cited by 217
The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition
Nordlund, A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.050385 · Cited by 213
AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease
Lovestone, S., Francis, P. T., Kłoszewska, I., Mecocci, P., Simmons, A., Soininen, H. S., Spenger, C., Tsolaki, M., Vellas, B. J., Wahlund, L., et al. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05064.x · Cited by 211
Fjell, A. M., Walhovd, K. B., Fennema‐Notestine, C., McEvoy, L. K., Hagler, D. J., Holland, D., Brewer, J. B., Dale, A. M., & Initiative, A. D. N. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3785-09.2010 · Cited by 211
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment
Carmichael, O. T., Aizenstein, H. J., Davis, S. W., Becker, J. T., Thompson, P. M., MELTZER, C. C., & Liu, Y. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.005 · Cited by 208
Schmitter, D., Roche, A., Maréchal, B., Ribes, D., Abdulkadir, A., Cuadra, M. B., Daducci, A., Granziera, C., Klöppel, S., Maeder, P. P., et al. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.11.001 · Cited by 206
Predicting MCI outcome with clinically available MRI and CSF biomarkers
Heister, D. S., Brewer, J. B., Magda, S., Blennow, K., McEvoy, L. K., & Initiative, A. D. N. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343314 · Cited by 206
Moradi, E., Hallikainen, I. T., Hänninen, T., & Tohka, J. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.011 · Cited by 205
Korolev, I. O., Symonds, L. L., Bozoki, A., & Initiative, A. D. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0138866 · Cited by 203
Cho, Y., Seong, J., Jeong, Y., & Shin, S. Y. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.085 · Cited by 201
Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease
Teipel, S. J., Grothe, M. J., Lista, S., Toschi, N., Garaci, F., & Hampel, H. J. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.12.013 · Cited by 198
Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease
Chincarini, A., Bosco, P., Calvini, P., Gemme, G., Esposito, M. P., Olivieri, C., Rei, L., SQUARCIA, S., Rodriguez, G., Bellotti, R., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.083 · Cited by 197
Reporting standards for studies of diagnostic test accuracy in dementia
Noel-Storr, A. H., McCleery, J. M., Richard, E., Ritchie, C. W., Flicker, L. A., Cullum, S. J., Davis, D. H. J., Quinn, T. J., Hyde, C., Rutjes, A. W., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000621 · Cited by 196
Differential Cortical Atrophy in Subgroups of Mild Cognitive Impairment
Bell‐McGinty, S., López, O. L., MELTZER, C. C., Scanlon, J. M., Whyte, E. M., DeKosky, S. T., & Becker, J. T. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.1393 · Cited by 196
MRI predictors of risk of incident Alzheimer disease
Stoub, T. R., Bulgakova, M., Leurgans, S. E., Bennett, D. A., Fleischman, D. A., Turner, D. A., & deToledo‐Morrell, L. (2005) · Neurology · doi:10.1212/01.wnl.0000160089.43264.1a · Cited by 193
Domain Transfer Learning for MCI Conversion Prediction
Cheng, B., Liu, M., Zhang, D., Munsell, B. C., & Shen, D. G. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2404809 · Cited by 192
Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia
Galton, C. J. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.2.165 · Cited by 187
Scheltens, P., Pasquier, F., Weerts, J. G. E., Barkhof, F., & Leys, D. (2008) · European Neurology · doi:10.1159/000117417 · Cited by 185
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Prestia, A., Caroli, A., van der Flier, W. M., Ossenkoppele, R., Van Berckel, B., Barkhof, F., Teunissen, C. E., Wall, A. E., Carter, S. F., Schöll, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182872830 · Cited by 184
Self-citationCSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment
Bouwman, F. H., Schoonenboom, S. N. M., van der Flier, W. M., van Elk, E. J., Kok, A., Barkhof, F., Blankenstein, M. A., & Scheltens, P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.006 · Cited by 182
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment
Fleisher, A., Sun, S., Taylor, C., Ward, C., Gamst, A. C., Petersen, R. C., Jack, C. R., Aisen, P. S. S., & Thal, L. J. (2008) · Neurology · doi:10.1212/01.wnl.0000287091.57376.65 · Cited by 180
Douaud, G., Menke, R. A. L., Gass, A., Monsch, A. U., Rao, A., Whitcher, B., Zamboni, G., Matthews, P. M., Sollberger, M., & Smith, S. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4437-12.2013 · Cited by 180
Grothe, M. J., Heinsen, H., & Teipel, S. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.018 · Cited by 179
Robust whole-brain segmentation: Application to traumatic brain injury
Ledig, C., Heckemann, R. A., Hammers, A., López‐Azor, J. C., Newcombe, V., Makropoulos, A., Lötjönen, J. M. P., Menon, D. K., & Rueckert, D. (2014) · Medical Image Analysis · doi:10.1016/j.media.2014.12.003 · Cited by 175
Atrophy rates accelerate in amnestic mild cognitive impairment
Jack, C. R., Weigand, S. D., Shiung, M. M., Przybelski, S. A., O’Brien, P. C., Gunter, J. L., Knopman, D. S., Boeve, B. F., Smith, G. E., & Petersen, R. C. (2007) · Neurology · doi:10.1212/01.wnl.0000281688.77598.35 · Cited by 175
Ledig, C., Schuh, A., Guerrero, R., Heckemann, R. A., & Rueckert, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-29295-9 · Cited by 175
Karas, G. B., Sluimer, J. D., Goekoop, R., van der Flier, W. M., Rombouts, S. A. R. B., Vrenken, H., Scheltens, P., Fox, N. C., & Barkhof, F. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0949 · Cited by 173
Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type
Wang, L., Miller, J. P., Gado, M. H., McKeel, D. W., Rothermich, M. A., Miller, M. I., Morris, J. C., & Csernansky, J. G. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.09.017 · Cited by 171
Cerebral atrophy in mild cognitive impairment and Alzheimer disease
Leung, K. K., Bartlett, J. W., Barnes, J., Manning, E. N., Sebastien Ourselin, A., Fox, N. C., & Initiative, A. D. N. (2013) · Neurology · doi:10.1212/wnl.0b013e318281ccd3 · Cited by 171
MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study
Tapiola, T., Pennanen, C., Tapiola, M., Tervo, S., Kivipelto, M., Hänninen, T., Pihlajamaki, M. M., Laakso, M. P., Hallikainen, M., Hämäläinen, A., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.007 · Cited by 169
Self-citationRitchie, C. W., Smailagic, N., Noel-Storr, A. H., Takwoingi, Y., Flicker, L. A., Mason, S., & McShane, R. H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008782.pub4 · Cited by 167
Kantarci, K., Weigand, S. D., Przybelski, S. A., Shiung, M. M., Whitwell, J. L., Negash, S., Knopman, D. S., Boeve, B. F., O’Brien, P. C., Petersen, R. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e864 · Cited by 160
Dickerson, B. C. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00055 · Cited by 160
MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease
Devanand, D. P., Bansal, R., Liu, J., Hao, X., Pradhaban, G., & Peterson, B. S. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.075 · Cited by 156
Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial
Study, T. A. D. C., Grundman, M., Sencakova, D., Jack, C. R., Petersen, R. C., Kim, H. T., Schultz, A. N., Weiner, M., DeCarli, C. S., DeKosky, S. T., et al. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0006-6 · Cited by 153
Mah, L., Binns, M. A., & Steffens, D. C. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.10.005 · Cited by 150
Tang, X., Holland, D., Dale, A. M., Laurent Younes, B., Miller, M. I., & Initiative, A. D. N. (2014) · Human Brain Mapping · doi:10.1002/hbm.22431 · Cited by 148
Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data
Initiative, A. D. N., Ye, J., Farnum, M. A., Yang, E., Verbeeck, R., Lobanov, V. S., Raghavan, N., Novak, G., DiBernardo, A., & Narayan, V. A. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-46 · Cited by 148
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease
Fouquet, M., Desgranges, B., Landeau, B., Duchesnay, É., Mézenge, F., Sayette, V. D. L., Viader, F., Baron, J., Eustache, F., & Chételat, G. (2009) · Brain · doi:10.1093/brain/awp132 · Cited by 148
Da, X., Toledo, J. B., Zee, J., Wolk, D. A., Xie, S. X., Ou, Y., Shacklett, A., Parmpi, P., Shaw, L. M. J., Trojanowski, J. Q., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.11.010 · Cited by 144
Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment
Hämäläinen, A., Tervo, S., Grau-Olivares, M., Niskanen, E. I., Pennanen, C., Huuskonen, J., Kivipelto, M., Hänninen, T., Tapiola, M., Vanhanen, M., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.06.016 · Cited by 142
Leandrou, S., Petroudi, S., Kyriacou, P. A., Reyes‐Aldasoro, C. C., & Pattichis, C. S. (2018) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2018.2796598 · Cited by 142
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
Vos, S. J. B., van Rossum, I. A., Verhey, F. R. J., Knol, D. L., Soininen, H. S., Wahlund, L., Hampel, H. J., Tsolaki, M., Minthon, L., Frisoni, G. B., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318288690c · Cited by 140
Self-citationYi, H., Möller, C., Dieleman, N., Bouwman, F. H., Barkhof, F., Scheltens, P., van der Flier, W. M., & Vrenken, H. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309105 · Cited by 139
Staekenborg, S. S., Koedam, E. L. G. E., Henneman, W. J. P., Stokman, P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.108.531343 · Cited by 139
Injury markers predict time to dementia in subjects with MCI and amyloid pathology
van Rossum, I. A., Vos, S. J. B., Burns, L., Knol, D. L., Scheltens, P., Soininen, H., Wahlund, L.-O., Hampel, H., Tsolaki, M., Minthon, L., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182704056 · Cited by 136
Measurement of hippocampal atrophy using 4D graph-cut segmentation: Application to ADNI
Wolz, R., Heckemann, R. A., Aljabar, P., Hajnal, J. V., Hammers, A., Lötjönen, J. M. P., & Rueckert, D. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.006 · Cited by 133
Trzepacz, P. T., Yu, P., Sun, J., Schuh, K. J., Case, M. G., Witte, M. M., Hochstetler, H. M., & Hake, A. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.018 · Cited by 131
Structural imaging biomarkers of Alzheimer's disease: predicting disease progression
Eskildsen, S. F., Coupé, P., Fonov, V., Pruessner, J. C., & Collins, D. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.034 · Cited by 129
MRI Measures of Alzheimer's Disease and the AddNeuroMed Study
Simmons, A., Westman, E., Muehlboeck, S., Mecocci, P., Vellas, B. J., Tsolaki, M., Kłoszewska, I., Wahlund, L., Soininen, H. S., Lovestone, S., et al. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05063.x · Cited by 128
Feature Selection Based on the SVM Weight Vector for Classification of Dementia
Bron, E. E., Smits, M., Niessen, W. J., & Klein, S. (2015) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2015.2432832 · Cited by 125
Westman, E., Cavallin, L., Muehlboeck, J., Zhang, Y., Mecocci, P., Vellas, B. J., Tsolaki, M., Kłoszewska, I., Soininen, H. S., Spenger, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022506 · Cited by 123
Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations
Initiative, A. T. A. D. N., Evans, M. C., Barnes, J., Nielsen, C. F., Kim, L. G., Clegg, S., Blair, M., Leung, K. K., Douiri, A., Boyes, R. G., et al. (2009) · European Radiology · doi:10.1007/s00330-009-1581-5 · Cited by 122
Blasko, I., Jellinger, K. A., Kemmler, G., Krampla, W. W., Jungwirth, S., Wichart, I., Tragl, K. H., & Fischer, P. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.002 · Cited by 121
Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease
Lötjönen, J. M. P., Wolz, R., Koikkalainen, J. R., Julkunen, V., Thurfjell, L., Lundqvist, R., Waldemar, G., Soininen, H. S., & Rueckert, D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.062 · Cited by 118
Fellgiebel, A., Dellani, P. R., Greverus, D., Scheurich, A., Stoeter, P., & Müller, M. J. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.01.006 · Cited by 118
Kovačević, S., Rafii, M. S., & Brewer, J. B. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318192e745 · Cited by 117
Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients
Wahlund, L.-O., & Blennow, K. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01483-0 · Cited by 116
Liu, Y., Paajanen, T. I., Zhang, Y., Westman, E., Wahlund, L., Simmons, A., Tunnard, C., Sobów, T., Mecocci, P., Tsolaki, M., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.022 · Cited by 115
Ventricular volume and dementia progression in the Cardiovascular Health Study
Carmichael, O. T., Kuller, L. H., López, O. L., Thompson, P. M., Dutton, R. A., Lu, A. P., Lee, S. E., Lee, J. Y., Aizenstein, H. J., MELTZER, C. C., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.01.006 · Cited by 112
Wang, S., Zhang, Y., Liu, G., Phillips, P., & Yuan, T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150848 · Cited by 112
Alzheimer's Disease Risk Assessment Using Large-Scale Machine Learning Methods
Casanova, R., Hsu, F., Sink, K. M., Rapp, S. R., Williamson, J. D., Resnick, S. M., Espeland, M. A., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077949 · Cited by 107
Doust, J. A., Pietrzak, E., Sanders, S., & Glasziou, P. P. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.09.011 · Cited by 106
Relating one-year cognitive change in mild cognitive impairment to baseline MRI features
Duchesne, S., Caroli, A., Geroldi, C., Collins, D. L., & Frisoni, G. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.023 · Cited by 106
Self-citationGeroldi, C., Rossi, R., Calvagna, C., Testa, C., Bresciani, L., Binetti, G. G., Zanetti, O. O., & Frisoni, G. B. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.082651 · Cited by 105
Self-citationBombois, S., Debette, S., Bruandet, A., Delbeuck, X., Delmaire, C., Leys, D., & Pasquier, F. (2008) · Stroke · doi:10.1161/strokeaha.107.505206 · Cited by 103
Multimodal manifold-regularized transfer learning for MCI conversion prediction
Initiative, A. D. N., Cheng, B., Liu, M., Suk, H., Shen, D. G., & Zhang, D. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9356-x · Cited by 101
Carmichael, O. T., Kuller, L. H., López, O. L., Thompson, P. M., Dutton, R. A., Lu, A. P., Lee, S. E., Lee, J. Y., Aizenstein, H. J., MELTZER, C. C., et al. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318032d2b1 · Cited by 101
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
Ong, K. T., Villemagne, V. L., Bahar‐Fuchs, A., Lamb, F., Langdon, N., Catafau, A. M., Stephens, A. W., Seibyl, J. P., Dinkelborg, L. M., Reininger, C. B., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308094 · Cited by 100
Teipel, S. J., Kurth, J., Krause, B. J., & Grothe, M. J. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.05.006 · Cited by 100
Dyrba, M., Barkhof, F., Fellgiebel, A., Filippi, M., Hausner, L., Hauenstein, K., Kirste, T., Teipel, S. J., & the EDSD study group (2015) · Journal of Neuroimaging · doi:10.1111/jon.12214 · Cited by 99
Tosun, D., Schuff, N. W., Truran‐Sacrey, D., Shaw, L. M. J., Trojanowski, J. Q., Aisen, P. S. S., Peterson, R., & Weiner, M. W. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.030 · Cited by 99
Accelerating regional atrophy rates in the progression from normal aging to Alzheimer’s disease
Sluimer, J. D., van der Flier, W. M., Karas, G. B., van Schijndel, R. A., Barnes, J., Boyes, R. G., Cover, K. S., Olabarriaga, S. D., Fox, N. C., Scheltens, P., et al. (2009) · European Radiology · doi:10.1007/s00330-009-1512-5 · Cited by 99
Evaluating Alzheimer’s Disease Progression Using Rate of Regional Hippocampal Atrophy
Frankó, E., Joly, O., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071354 · Cited by 98
Clerx, L., van Rossum, I. A., Burns, L., Knol, D. L., Scheltens, P., Verhey, F., Aalten, P., Lapuerta, P., van de Pol, L., van Schijndel, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.002 · Cited by 98
Xu, L., Wu, X., Chen, K., & Yao, L. (2015) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2015.08.004 · Cited by 95
Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia
Cardenas, V. A., Du, A., Hardin, D., Ezekiel, F., Weber, P., Jagust, W. J., Chui, H. C., Schuff, N. W., & Weiner, M. W. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00130-6 · Cited by 94
Chincarini, A., Sensi, F., Rei, L., Gemme, G., Squarcia, S., Longo, R., Brun, F., Tangaro, S., Bellotti, R., Amoroso, N., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2015.10.065 · Cited by 94
Self-citationMRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD
Desikan, R. S., Fischl, B. R., Cabral, H., Kemper, T. L., Guttmann, C. R. G., Blacker, D., Hyman, B. T., Albert, M., & Killiany, R. (2008) · Neurology · doi:10.1212/01.wnl.0000320055.57329.34 · Cited by 93
Bron, E. E., Steketee, R. M. E., Houston, G. C., Oliver, R. A., Achterberg, H. C., Loog, M., van Swieten, J. C., Hammers, A., Niessen, W. J., Smits, M., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22522 · Cited by 93
Peters, F., Villeneuve, S., & Belleville, S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130842 · Cited by 92
Peng, G., Feng, Z., He, F., Chen, Z., Liu, X., Liu, P., & Luo, B. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12317 · Cited by 92
Perani, D., Cerami, C., Caminiti, S. P., Santangelo, R., Coppi, E., Ferrari, L. D., Pinto, P., Passerini, G., Falini, A., Iannaccone, S., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3170-y · Cited by 91
Alzheimer’s Disease: In Vivo Detection of Differential Vulnerability of Brain Regions
deToledo‐Morrell, L., Sullivan, M., Morrell, F., Wilson, R. S., Bennett, D. A., & Spencer, S. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00114-0 · Cited by 91
Mild cognitive impairment in clinical care
Roberts, J. S., Karlawish, J. H., Uhlmann, W. R., Petersen, R. C., & Green, R. C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181eb5872 · Cited by 90
Khan, W., Westman, E., Jones, N., Wahlund, L., Mecocci, P., Vellas, B. J., Tsolaki, M., Kłoszewska, I., Soininen, H. S., Spenger, C., et al. (2014) · Brain Topography · doi:10.1007/s10548-014-0415-1 · Cited by 88
Research works printed but not linked: 11
- Chertkow, 2012, Amnestic mild cognitive impairment in a memory clinic: longitudinal course and predictors of progression (abstract), Alzheimer's & Dementia, 8 Suppl 4, 482
- Citak-Er, 2017, A novel convolutional neural network model based on voxel-based morphometry of imaging data in predicting the prognosis of patients with mild cognitive impairment, Journal of Neurological Sciences, 34, 52
- Cover, 2016, The measurement of hippocampal atrophy rates with MRI for a 3-year study appears to be at least 3 times more sensitive than a 1-year study based on back-to-back reproducibility, Alzheimer's & Dementia, 12 Suppl 7, 99–100
- Kong, 2014, Role of imaging and genetic data for predicting time to conversion to Azheimer disease in patients with mild cognitive impairment, Annals of Neurology, 76 Suppl 18, S94
- Nesteruk, 2015, Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging, Neurologia i Neurochirurgia Polska, 49, 349, 10.1016/j.pjnns.2015.09.003 · DOI
- Maurik, 2016, Personalized risk estimates for MCI patients: taking biomarkers into the clinic, Alzheimer's & Dementia, 12 Suppl 7, P393
- Alzheimer’s Disease International, 2019, World Alzheimer Report 2019: Attitudes to Dementia
- Bossuyt P Davenport C Deeks J Hyde C Leeflang M Scholten R Chapter 11: Interpreting results and drawing conclusions. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.9. The Cochrane Collaboration, 2013 Available from: srdta.cochrane.org
- De Vet HC Eisinga A Riphagen II Aertgeerts B Pewsner D Chapter 7: Searching for Studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 (September 2008). The Cochrane Collaboration, 2008: Section 7.2.1.2 Available from srdta.cochrane.org/handbook-dta-reviews
- Galton, 2001, Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia, Journal of Neurology, Neurosurgery, and Psychiatry, 70, 165, 10.1136/jnnp.70.2.165 · DOI
- Yue, 1997, Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study, Radiology, 202, 33, 10.1148/radiology.202.1.8988189 · DOI
Cited by
Sorted by citations
Safiri, S., Jolfayi, A. G., Fazlollahi, A., Morsali, S., Sarkesh, A., Sorkhabi, A. D., Golabi, B., Aletaha, R., Asghari, K. M., Hamidi, S., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1474043 · Cited by 273
Quinn, T. J., Richard, E., Teuschl, Y., Gattringer, T., Hafdi, M., O'Brien, J. T., Merriman, N. A., Gillebert, C. R., Huygelier, H., Verdelho, A., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15068 · Cited by 201
XGBoost-SHAP-based interpretable diagnostic framework for alzheimer’s disease
Yi, F., Yang, H., Chen, D., Qin, Y., Han, H., Cui, J., Bai, W., Ma, Y., Zhang, R., & Yu, H. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02238-9 · Cited by 205
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Chouliaras, L., & O’Brien, J. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02215-8 · Cited by 221
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Metadata
- Authors
- Lombardi, G., Crescioli, G., Cavedo, E., Lucenteforte, E., Casazza, G., Bellatorre, A.-G., Lista, C., Costantino, G., Frisoni, G., Virgili, G., & Filippini, G.
- Affiliations
- University of Florence (IT)
- Sorbonne Université (FR)
- University of Pisa (IT)
- University of Milan (IT)
- Azienda sanitaria universitaria Friuli Centrale (IT)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Geneva (CH)
- ORCID
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2020-03-02
- Volume
- 2020
- Issue
- 3
- Pages
- CD009628-CD009628
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC7059964
- OpenAlex
- W3009532950
- Cited by
- 214
- References
- 391
- Citations by year
- 2026: 16 · 2025: 51 · 2024: 47 · 2023: 47 · 2022: 21 · 2021: 19 · 2020: 13
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- structural MRI, Alzheimer's disease, mild cognitive impairment, early diagnosis, dementia, diagnostic accuracy, brain atrophy, hippocampal atrophy, medial temporal lobe, entorhinal cortex, amygdala, lateral ventricle, gray matter atrophy, volumetric MRI, visual assessment, conversion to dementia, white matter hyperintensities, amyloid imaging, neurodegeneration biomarkers, medial temporal lobe atrophy
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Atrophy, Brain, Hippocampus, Humans, Magnetic Resonance Imaging, Middle Aged, Organ Size, Prospective Studies, Sensitivity and Specificity, Temporal Lobe, Disease Progression, Entorhinal Cortex, Lateral Ventricles, Neuroimaging, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
